Zomedica Corp. (ZOMDF)
0.0789
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Zomedica Net Income (Quarterly) : -3.765M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.765M |
| March 31, 2026 | -4.534M |
| December 31, 2025 | -4.53M |
| September 30, 2025 | -6.121M |
| June 30, 2025 | -7.398M |
| March 31, 2025 | -63.81M |
| December 31, 2024 | -7.194M |
| September 30, 2024 | -6.697M |
| June 30, 2024 | -23.93M |
| March 31, 2024 | -9.16M |
| December 31, 2023 | -22.41M |
| September 30, 2023 | -0.491M |
| June 30, 2023 | -5.249M |
| March 31, 2023 | -6.385M |
| December 31, 2022 | -2.809M |
| September 30, 2022 | -4.995M |
| June 30, 2022 | -5.273M |
| March 31, 2022 | -3.937M |
| December 31, 2021 | -3.29M |
| September 30, 2021 | -6.346M |
| June 30, 2021 | -4.711M |
| March 31, 2021 | -4.037M |
| December 31, 2020 | -4.173M |
| September 30, 2020 | -4.98M |
| June 30, 2020 | -5.308M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.451M |
| December 31, 2019 | -2.857M |
| September 30, 2019 | -2.846M |
| June 30, 2019 | -2.404M |
| March 31, 2019 | -11.68M |
| December 31, 2018 | -8.422M |
| September 30, 2018 | -1.910M |
| June 30, 2018 | -4.144M |
| March 31, 2018 | -2.171M |
| December 31, 2017 | |
| September 30, 2017 | -2.081M |
| June 30, 2017 | -1.588M |
| March 31, 2017 | -1.833M |
| December 31, 2016 | -2.974M |
| September 30, 2016 | -1.042M |
| June 30, 2016 | -1.065M |
| March 31, 2016 | -0.9316M |
| February 29, 2016 | |
| November 30, 2015 | |
| August 31, 2015 | |
| May 31, 2015 | |
| February 28, 2015 | -0.0186M |
| November 30, 2014 | -0.009M |
| August 31, 2014 | -0.0112M |
| May 31, 2014 | -0.0078M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Biomerica, Inc. | -1.145M |
| Univec, Inc. | -0.3115M |
| Lantheus Holdings, Inc. | 75.03M |
| IDEXX Laboratories, Inc. | 338.41M |
| Neogen Corp. | -11.30M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 9.512M |
| Total Expenses (Quarterly) | 13.28M |
| EPS Diluted (Quarterly) | -0.0038 |
| Enterprise Value | 34.99M |
| Gross Profit Margin (Quarterly) | 63.51% |
| Profit Margin (Quarterly) | -39.58% |
| Earnings Yield | -24.34% |
| Normalized Earnings Yield | -24.47 |